&Partners’s Zimmer Biomet ZBH Stock Holding History

&Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.2M	Buy	25,534 +4,007	+19%	+$351K	0.01%	968
2026 Q1	$1.95M	Buy	21,527 +1,926	+10%	+$177K	0.01%	921
2025 Q4	$1.75M	Sell	19,601 -5,657	-22%	-$536K	0.01%	931
2025 Q3	$2.48M	Buy	25,258 +3,128	+14%	+$310K	0.02%	672
2025 Q2	$2.02M	Buy	22,130 +7,592	+52%	+$734K	0.02%	666
2025 Q1	$1.63M	Buy	14,538 +3,546	+32%	+$379K	0.02%	621
2024 Q4	$1.15M	Buy	10,992 +6,161	+128%	+$661K	0.01%	713
2024 Q3	$521K	Buy	4,831 +2,135	+79%	+$233K	0.01%	852
2024 Q2	$293K	Buy	+2,696	New	+$318K	0.01%	722

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

&Partners's ZBH Position: Q2 2026 in Review

&Partners increased its Zimmer Biomet (ZBH) stake by 19% in Q2 2026, buying an estimated $351K and bringing the position to 25,534 shares worth $2.2M. The position accounts for 0.01% of the portfolio, ranked #968.

&Partners first reported a position in ZBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.48M in Q3 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

&Partners held 25,534 shares of Zimmer Biomet worth $2.2M as of Q2 2026.
&Partners bought 4,007 Zimmer Biomet shares in Q2 2026, an estimated $351K.
Zimmer Biomet made up 0.01% of &Partners's portfolio in Q2 2026, its #968 holding.
&Partners first reported a position in Zimmer Biomet in Q2 2024 and has held it in 9 quarters since.
&Partners's Zimmer Biomet position peaked at $2.48M in Q3 2025.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.